Solutions 4 Wealth »

Outlook Therapeutics shares owned by Solutions 4 Wealth

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Solutions 4 Wealth from 13F filings

Historical chart of Solutions 4 Wealth investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Solutions 4 Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Solutions 4 Wealth

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 33k 0.39

More positions owned by Solutions 4 Wealth

Invesco Van Kampen Senior Income Trust (VVR)
Select Sector Spdr Tr Technology (XLK)
Select Sector Spdr Tr Financial (XLF)
First Tr Mid Cap Core Alphad Com Shs (FNX)
Apple (AAPL)
Global X Fds Nasdaq 100 Cover (QYLD)
Vanguard World Health Car Etf (VHT)
Veritex Hldgs (VBTX)
Exchange Traded Concepts Tru Robo Glb Etf (ROBO)
Ishares Tr Cybersecurity (IHAK)
Global X Fds Russell 2000 (RYLD)
Ishares Tr U.s. Med Dvc Etf (IHI)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Southside Bancshares (SBSI)
Vanguard Index Fds Sml Cp Grw Etf (VBK)

View all positions for Solutions 4 Wealth

Top funds holding Outlook Therapeutics

Vanguard Group
Charles Schwab Investment Management
Rosalind Advisors
Scotia Capital
Millennium Management
Bank of America Corporation
Barclays
Rhumbline Advisers
Gables Capital Management
UBS Group
Ancora Advisors
Jpmorgan Chase & Co
Alliancebernstein
American International
Captrust Financial Advisors

View all funds holding Outlook Therapeutics